CSA Medical, Inc. develops and manufactures a proprietary interventional spray cryotherapy technology platform comprised of a device and specialty catheters that enable delivery of spray cryogen inside the body to flash freeze and destroy unwanted tissue. The Company is the first to harness the power of low pressure, extremely cold (-196o C) liquid nitrogen inside the body.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/23/13 | $16,000,000 | Series C |
Ascension Health Ventures Blue Heron Capital First Analysis Guide Medical Ventures Intersouth Partners Rose Park Advisors | undisclosed |
| 09/09/24 | $53,000,000 | Series D |
Ascension Ventures Blue Heron Capital First Analysis Intersouth Partners SV Health Investors TVM Capital Life Science  Yonjin Capital | undisclosed |
